Adenoviral conjunctivitis is a common condition that is aggressively contagious, and therefore, requires early diagnosis. Often the best course of action is to let the infection run its course; however, some possible treatments are currently being investigated. One of these is a combination of dexamethasone and povidone-iodine, which is hoped will remove the infection quicker and reduce inflammation. The other experimental treatment is brincidofovir, which has shown efficacy in systemic adenoviral infection, though not specifically in the eye. In an expert interview filmed at AAO 2018, editorial board member Dr Bennie Jeng discusses the complications and potential treatment options for adenoviral conjunctivitis. He explains that while treatment with corticosteroids is not ideal, and something he tries to avoid, it can sometimes be necessary for highly symptomatic patients or those with subepithelial infiltrates which could result in scarring. Infiltrates can be very responsive to steroids; however, they may reoccur many times, leaving the patient reliant on steroids for an extended time. Dr Jeng explains how to manage these patients and the best methods for tapering patients off steroids.
1. What are the common clinical presentations of adenoviral conjunctivitis? (0:11)
2. What are the consequences of delayed diagnosis of adenoviral conjunctivitis? (0:32)
3. What are the most effective ways of managing the condition? (1:12)
4. What is your opinion on the use of corticosteroids for the treatment of subepithelial infiltrates? (3:17)
Speaker disclosures: Bennie Jeng has nothing to disclose in relation to this interview.
Filmed at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting, Chicago, IL, US, 27–30 October 2018.
Share this Video
Related Videos In Corneal Disorders
Karolinne M Rocha, Kiaweh Eye 2021: Corneal Epithelial Thickness Mapping
It was a pleasure to catch up with Karolinne M Rocha (Medical University of South Carolina, SC, USA) about advances in corneal epithelial thickness mapping technology in the past year. How has corneal epithelial thickness mapping helped in the detection of subclinical early-stage keratoconus? (00:19) What have been the major advances in corneal epithelial thickness […]
Karolinne M Rocha, Kiaweh Eye 2021: The Role of the Corneal Epithelium and Methods to Assess Corneal Epithelial Thickness
We were delighted to speak with Karolinne M Rocha (Medical University of South Carolina, SC, USA) about the role of the corneal epithelium in the refractive system of the eye, and the usefulness of knowledge of the corneal epithelial thickness profile in cataract surgery. What is the role of the corneal epithelium in the refractive […]
Jorge L Alió, EGS 2020 – Corneal Regeneration, Will It Be a Reality in 2021?
We were delighted to talk with our Editorial Board member, Jorge L. Alió (Miguel Hernández University of Alicante, Elche, Spain) about the recent technological advances in corneal regeneration. Questions Could you tell us a little about the challenges and opportunities of corneal regeneration? (0:05) What have been the most exciting recent technological advances in corneal […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!